Herein, we describe the possible management of bronchial asthma, including steroid-resistant endotypes by targeting LAT1, summarizing the recent establishment of asthma pathogenesis, including the contribution of LAT1, and efforts to generate a novel LAT1 inhibitor. The gene discussed is LAT; the disease is asthma.